The prevalence and clinical characteristics of diabetic neuropathy in ...

More documents

Recommendations

Info

$Microsoft PowerPoint - S14-1_\300\374\274\272\277\317 [\310\243 ...$

$Microsoft PowerPoint - src.ppt [\310\243\310\257 \270\360\265\345]$

$Microsoft PowerPoint - S7-1_\300\374\277\353\260\374$

$Microsoft PowerPoint - src.ppt [\310\243\310\257 \270\360\265\345]$

$(Microsoft PowerPoint - WDXKRSAWSXRU.ppt [\310\243\310\257 ...$

Clinical characteristics of DPN in Korea (2)(n, %) DPN (1,338, 33.5) Non-DPN (2,661, 66.5)Systolic BP (mm Hg) 127.5 ± 15.5 127.0 ± 14.4Diastolic BP (mm Hg) 74.5 ± 10.3 75.3 ± 9.8Fasting plasma glucose (mmol/L) 7.9 ± 3.1 7.9 ± 2.7A1C (%) 7.8 ± 2.4 7.6 ± 2.9Total cholesterol (mmol/L) 4.4 ± 1.1 4.4 ± 1.1Triglyceride (mmol/L) 1.6 ± 1.0 1.7 ± 1.2HDL-cholesterol (mmol/L) 1.2 ± 0.4 1.2 ± 0.3LDL-cholesterol (mmol/L) 2.4 ± 0.9* 2.6 ± 0.9Data are mean ± SD. * P < 0.05 vs Non-DPN. BP, blood pressure; A1C, hemoglobin A1 C ; HDL, high density lipoprotein;LDL, low density lipoprotein.
Clinical characteristics of DPN in Korea (3)(n, %) DPN (1,338, 33.5) Non-DPN (2,661, 66.5)Hypertension (%) 65.7* 50.8Dyslipidemia (%) 52.6* 46.9Any retinopathy (%) 31.8* 15.6Nephropathy (%) 22.5* 12.3History of CVDs (%) 12.0* 6.8History of CVAs (%) 6.4* 4.0History of PADs (%) 7.3* 1.5Foot ulcer or amputation (%) 3.1* 0.3MNSI scores 3.1 ± 2.2* 1.5 ± 1.5Abnormal site of monofilament test (n)Rt. FootLt. foot1.8 ± 2.6*1.8 ± 2.6*0.3 ± 1.00.3 ± 1.0Data are mean ± SD. * P < 0.05 vs non-DPN.; CVD, cardiovascular disease; CVA, cerebrovascular accident; PAD,peripheral arterial disease; MNSI, Michigan Neuropathy Screening Instrument.
Page 1 and 2: The prevalence and clinicalcharacte
Page 4 and 5: •Diabetes was associated with 2-3
Page 6 and 7: Total medical cost in patients with
Page 8 and 9: DISCLOSUREAnalysis of data from the
Page 10 and 11: Prevalence of diabetic neuropathy i
Page 12 and 13: Prevalence of DPNN = 3,339Non-DPNDP
Page 16 and 17: Prevalence of DPN according to thed
Page 18 and 19: Temporal prevalence (%) of diabetic
Page 20 and 21: ORs of risk factors associated with
Page 22 and 23: Comparison of MNSI symptom distribu
Page 24 and 25: DPN: treatmentTreatment (+) Treatme
Page 26 and 27: BPI-SF (1): Pain severityNon-DPNDPN
Page 28 and 29: MOS-sleep scale• 당신솟이 필
Page 31 and 32: EQ-5D descriptive system: 5 dimensi
Page 33 and 34: Patients awareness of DPNAwarenessY
Page 35 and 36: Investigators and study centersincl
Page 37: Thank you for your attention!

The prevalence and clinical characteristics of diabetic neuropathy in ...

Create successful ePaper yourself

Delete template?

Save as template?